Characteristics and Results of the Management of Diffuse Large B-Cell Lymphomas: The Experience of Côte d'Ivoire

Table 5

Relationship between the therapeutic response and the general characteristics of patients.

Parameters	Univariate analysis Complete response	𝑃
Age (years)
<60	22/52 (42)	0.552
≥60	5/11 (45)
Sex
Male	18/42 (43)	0.787
Female	9/21 (43)
Socioeconomic standing
Low	7/32 (22)	0.001
Medium	13/22 (59)
High	7/9 (77)
IPI
Low risk (0, 1)	5/6 (83)	<0.0001
Intermediate risk (2)	13/16 (81)
High risk (≥3)	9/41 (22)
Site
Nodal	18/37 (49)	0.395
Extranodal	9/26 (35)
Consultation period (month)
<3	10/15 (67)	0.06
3–6	10/26 (38)
>6	7/22 (32)
Stage of Ann Arbor
I, II	16/18 (89)	<0.0001
III, IV	11/45 (24)
Clinical B symptoms
No	8/16 (50)	0.706
Yes	19/47 (40)
Biological b symptoms
No	17/26 (65)	0.01
Yes	5/37 (13)